Comparison of interferon monotherapy with interferon-lamivudine combination treatment in children with chronic hepatitis B.
暂无分享,去创建一个
[1] S. Aydoğdu,et al. Effect of Long-Term Lamivudine in Chronic Hepatitis B Virus-Infected Children , 2003, Antiviral therapy.
[2] A. Kansu,et al. Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study. , 2003, Journal of gastroenterology and hepatology.
[3] Man-Fung Yuen,et al. Viral hepatitis B , 2003, The Lancet.
[4] Y. Liaw. Results of lamivudine trials in Asia. , 2003, Journal of hepatology.
[5] B. Dikici,et al. Comparison of treatments of chronic hepatitis B in children with lamivudine and α‐interferon combination and α‐interferon alone , 2002, Pediatrics international : official journal of the Japan Pediatric Society.
[6] F. Ünal,et al. Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children , 2002, Pediatrics international : official journal of the Japan Pediatric Society.
[7] G. Usluer,et al. Comparison of Different Treatment Combinations for Chronic Hepatitis B Infection , 2002, Journal of chemotherapy.
[8] E. Sokal. Drug Treatment of Pediatric Chronic Hepatitis B , 2002, Paediatric drugs.
[9] B. Dikici,et al. Lamivudine and interferon-alpha combination treatment of childhood patients with chronic hepatitis B infection. , 2001, The Pediatric infectious disease journal.
[10] G. Barbarini,et al. Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial. , 2001, Journal of hepatology.
[11] S. Schalm. Lamivudine-interferon combination therapy for chronic hepatitis B: further support but no conclusive evidence. , 2001, Journal of hepatology.
[12] N. Leung,et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy , 2001, Hepatology.
[13] D. Pillay,et al. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection. , 2000, Antiviral therapy.
[14] J. Hoofnagle,et al. Long‐term therapy of chronic hepatitis B with lamivudine , 2000, Hepatology.
[15] Y. Liaw,et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. , 2000, Gastroenterology.
[16] C. Chu,et al. Clearance of the original hepatitis B virus YMDD‐motif mutants with emergence of distinct lamivudine‐resistant mutants during prolonged lamivudine therapy , 2000, Hepatology.
[17] Ally,et al. A ONE-YEAR TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS B , 2000 .
[18] E. Schiff,et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. , 1999, The New England journal of medicine.
[19] N. Leung,et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. , 1998, The New England journal of medicine.
[20] J. Sarles,et al. Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. , 1998, Gastroenterology.
[21] D. Torre,et al. Interferon-α Therapy for Chronic Hepatitis B in Children: A Meta-Analysis , 1996 .
[22] D. Torre,et al. Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] J. Bartolomé,et al. Factors predictive of response to interferon therapy in children with chronic hepatitis B. , 1995, Journal of hepatology.
[24] J. de Groote,et al. [Classification of chronic hepatitis]. , 1968, Deutsche medizinische Wochenschrift.